NO20002696D0 - Nye forbindelser med cGMP-PDE-inhibitoreffekt - Google Patents
Nye forbindelser med cGMP-PDE-inhibitoreffektInfo
- Publication number
- NO20002696D0 NO20002696D0 NO20002696A NO20002696A NO20002696D0 NO 20002696 D0 NO20002696 D0 NO 20002696D0 NO 20002696 A NO20002696 A NO 20002696A NO 20002696 A NO20002696 A NO 20002696A NO 20002696 D0 NO20002696 D0 NO 20002696D0
- Authority
- NO
- Norway
- Prior art keywords
- cgmp
- new compounds
- pde inhibitor
- inhibitor effect
- effect
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP34416497 | 1997-11-28 | ||
| PCT/JP1998/005350 WO1999028319A1 (fr) | 1997-11-28 | 1998-11-27 | NOUVEAUX COMPOSES PRESENTANT UN EFFET INHIBITEUR DE cGMP-PDE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20002696D0 true NO20002696D0 (no) | 2000-05-26 |
| NO20002696L NO20002696L (no) | 2000-07-24 |
Family
ID=18367131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20002696A NO20002696L (no) | 1997-11-28 | 2000-05-26 | Nye forbindelser med cGMP-PDE-inhibitoreffekt |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6476021B1 (no) |
| EP (1) | EP1048666A4 (no) |
| KR (1) | KR20010032546A (no) |
| CN (1) | CN1284075A (no) |
| AU (1) | AU746883B2 (no) |
| BR (1) | BR9815070A (no) |
| CA (1) | CA2311947A1 (no) |
| HU (1) | HUP0100083A3 (no) |
| IL (1) | IL136340A0 (no) |
| MX (1) | MXPA00005190A (no) |
| NO (1) | NO20002696L (no) |
| PL (1) | PL340789A1 (no) |
| WO (1) | WO1999028319A1 (no) |
| ZA (1) | ZA9810766B (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2335809A1 (en) | 1998-06-23 | 1999-12-29 | Glaxo Group Limited | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| AU5204800A (en) * | 1999-06-21 | 2001-01-09 | Biochemical Pharmaceutical Factory of Zhuhai Sez, The | Process for preparing sildenafil, and troche which comprises sildenafil and apomorphine |
| DE19954707A1 (de) * | 1999-11-13 | 2001-05-17 | Merck Patent Gmbh | Imidazolverbindungen als Phosphodiesterase VII-Hemmer |
| IL151695A0 (en) | 2000-03-15 | 2003-04-10 | Aventis Pharma Gmbh | Substituted beta-carbolines with ikb-kinase inhibiting activity |
| WO2001068648A1 (en) * | 2000-03-15 | 2001-09-20 | Aventis Pharma Deutschland Gmbh | Substituted beta-carbolines with ikb-kinase inhibiting activity |
| CA2407031A1 (en) | 2000-04-19 | 2001-10-25 | Lilly Icos Llc | Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease |
| US6271228B1 (en) * | 2000-04-28 | 2001-08-07 | Pfizer Inc. | Blood pressure stabilization during hemodialysis |
| UA80258C2 (en) * | 2001-09-06 | 2007-09-10 | Biogen Inc | Methods of treating pulmonary disease |
| US20050107394A1 (en) * | 2001-12-17 | 2005-05-19 | Ardeschir Ghofrani | Novel use of selective pde5 inhibitors |
| GB0202254D0 (en) * | 2002-01-31 | 2002-03-20 | Pfizer Ltd | Prevention of scarring |
| US8133903B2 (en) | 2003-10-21 | 2012-03-13 | Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center | Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases |
| US7601856B2 (en) * | 2006-07-27 | 2009-10-13 | Wyeth | Benzofurans as potassium ion channel modulators |
| US7662831B2 (en) * | 2006-07-27 | 2010-02-16 | Wyeth Llc | Tetracyclic indoles as potassium channel modulators |
| WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
| CN115872991A (zh) * | 2021-09-26 | 2023-03-31 | 深圳大学 | β-咔伯啉生物碱类化合物及其药用组合物、制备方法和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS261338B1 (cs) * | 1987-09-17 | 1989-06-15 | Viktor Zikan | Způsob přípravy 10-nitro-4-oxo-4H-chino/2,3,4-i,j//1,4/benzoxazinových derivátů |
| GB9126260D0 (en) * | 1991-12-11 | 1992-02-12 | Pfizer Ltd | Therapeutic agents |
| JPH0710843A (ja) * | 1993-03-31 | 1995-01-13 | Eisai Co Ltd | 含窒素縮合複素環化合物 |
| PH31122A (en) * | 1993-03-31 | 1998-02-23 | Eisai Co Ltd | Nitrogen-containing fused-heterocycle compounds. |
| DE69533057T2 (de) * | 1994-08-09 | 2005-06-16 | Eisai Co., Ltd. | Kondensierte pyridazinverbindungen |
| GB9423910D0 (en) * | 1994-11-26 | 1995-01-11 | Pfizer Ltd | Therapeutic agents |
| JP3713783B2 (ja) * | 1995-01-20 | 2005-11-09 | 大正製薬株式会社 | １Ｈ−ピラゾロ［３，４−ｄ］ピリミジン−４−オン誘導体 |
| EP0985671B1 (en) * | 1996-05-31 | 2003-04-02 | Mochida Pharmaceutical Co., Ltd. | PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT |
| BR9809508A (pt) * | 1997-05-29 | 2000-06-20 | Mochida Pharm Co Ltd | Agente terapêutico para disfunção de ereção |
| AU5067098A (en) * | 1997-11-26 | 1999-06-15 | Mochida Pharmaceutical Co., Ltd. | Pyridocarbazole derivatives with cgmp-pde inhibitory activity |
-
1998
- 1998-11-25 ZA ZA9810766A patent/ZA9810766B/xx unknown
- 1998-11-27 IL IL13634098A patent/IL136340A0/xx unknown
- 1998-11-27 PL PL98340789A patent/PL340789A1/xx not_active Application Discontinuation
- 1998-11-27 MX MXPA00005190A patent/MXPA00005190A/es unknown
- 1998-11-27 CN CN98813341A patent/CN1284075A/zh active Pending
- 1998-11-27 WO PCT/JP1998/005350 patent/WO1999028319A1/ja not_active Application Discontinuation
- 1998-11-27 KR KR1020007005789A patent/KR20010032546A/ko not_active Application Discontinuation
- 1998-11-27 AU AU12617/99A patent/AU746883B2/en not_active Ceased
- 1998-11-27 CA CA002311947A patent/CA2311947A1/en not_active Abandoned
- 1998-11-27 HU HU0100083A patent/HUP0100083A3/hu unknown
- 1998-11-27 BR BR9815070-7A patent/BR9815070A/pt not_active IP Right Cessation
- 1998-11-27 EP EP98955965A patent/EP1048666A4/en not_active Withdrawn
-
2000
- 2000-05-26 NO NO20002696A patent/NO20002696L/no not_active Application Discontinuation
- 2000-05-26 US US09/580,657 patent/US6476021B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0100083A3 (en) | 2002-01-28 |
| HUP0100083A2 (hu) | 2001-08-28 |
| BR9815070A (pt) | 2000-10-03 |
| NO20002696L (no) | 2000-07-24 |
| ZA9810766B (en) | 1999-05-25 |
| EP1048666A1 (en) | 2000-11-02 |
| MXPA00005190A (es) | 2002-04-24 |
| EP1048666A4 (en) | 2001-10-31 |
| CA2311947A1 (en) | 1999-06-10 |
| CN1284075A (zh) | 2001-02-14 |
| AU746883B2 (en) | 2002-05-02 |
| WO1999028319A1 (fr) | 1999-06-10 |
| PL340789A1 (en) | 2001-02-26 |
| AU1261799A (en) | 1999-06-16 |
| US6476021B1 (en) | 2002-11-05 |
| IL136340A0 (en) | 2001-05-20 |
| KR20010032546A (ko) | 2001-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20003808D0 (no) | Substituerte oksoazaheterosyklylfaktor Xa inhibitorer | |
| NO993022D0 (no) | Nye forbindelser med analgetisk effekt | |
| NO20000226L (no) | Nye spiroazabicykliske heterocykliske forbindelser | |
| NO993023D0 (no) | Nye forbindelser med analgetisk effekt | |
| ATE245142T1 (de) | No-synthase inhibitoren | |
| NO982807L (no) | Nye forbindelser med analgetisk virkning | |
| PT1224195E (pt) | C-aril-glicosidos inibidores de tgls2 | |
| DK1027332T3 (da) | Hidtil ukendte lactametalloproteaseinhibitorer | |
| ATE460424T1 (de) | Factor viia inhibitore | |
| FI4209U1 (fi) | Uusia yhdisteitä | |
| NO996572L (no) | Nye substituerte imidazolforbindelser | |
| NO20001938D0 (no) | Nye aryloksy-alkyl-dialkylaminer | |
| NO20002696D0 (no) | Nye forbindelser med cGMP-PDE-inhibitoreffekt | |
| ATE252547T1 (de) | Matrixmetalloproteinaseinhibitoren | |
| NO20005857D0 (no) | Nye blandinger | |
| NO982863D0 (no) | Nye forbindelser med analgetisk effekt | |
| DK1019042T3 (da) | Forbindelser med anti-første-passagevirkning | |
| ID22727A (id) | Senyawa ester | |
| NO995430D0 (no) | Nye heterosykliske forbindelser | |
| NO993782D0 (no) | Nye forbindelser med hemoregulerende effekt | |
| DK0946511T3 (da) | Hidtil ukendte forbindelser med analgesisk virkning | |
| IDP000021790A (id) | Senyawa-senyawa pirolum tersubstitusi | |
| SE9800511D0 (sv) | New compounds | |
| SE9803747D0 (sv) | New compounds | |
| SE9803746D0 (sv) | New compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |